- Home
- MYNZ vs IBG Comparison
MYNZ vs IBG Comparison
Compare MYNZ & IBG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYNZ
- IBG
- Stock Information
- Founded
- MYNZ 2021
- IBG 2018
- Country
- MYNZ Germany
- IBG Australia
- Employees
- MYNZ N/A
- IBG N/A
- Industry
- MYNZ Biotechnology: Pharmaceutical Preparations
- IBG Beverages (Production/Distribution)
- Sector
- MYNZ Health Care
- IBG Consumer Staples
- Exchange
- MYNZ Nasdaq
- IBG Nasdaq
- Market Cap
- MYNZ 5.5M
- IBG 6.0M
- IPO Year
- MYNZ 2021
- IBG 2024
- Fundamental
- Price
- MYNZ $1.44
- IBG N/A
- Analyst Decision
- MYNZ Buy
- IBG Strong Buy
- Analyst Count
- MYNZ 2
- IBG 1
- Target Price
- MYNZ $14.00
- IBG N/A
- AVG Volume (30 Days)
- MYNZ 117.3K
- IBG 89.6K
- Earning Date
- MYNZ 07-15-2025
- IBG 07-11-2025
- Dividend Yield
- MYNZ N/A
- IBG N/A
- EPS Growth
- MYNZ N/A
- IBG N/A
- EPS
- MYNZ N/A
- IBG N/A
- Revenue
- MYNZ $893,991.00
- IBG $2,931,243.00
- Revenue This Year
- MYNZ $26.06
- IBG N/A
- Revenue Next Year
- MYNZ $4.97
- IBG N/A
- P/E Ratio
- MYNZ N/A
- IBG N/A
- Revenue Growth
- MYNZ N/A
- IBG N/A
- 52 Week Low
- MYNZ $1.34
- IBG $0.44
- 52 Week High
- MYNZ $22.40
- IBG $3.35
- Technical
- Relative Strength Index (RSI)
- MYNZ 26.61
- IBG N/A
- Support Level
- MYNZ $1.35
- IBG N/A
- Resistance Level
- MYNZ $1.46
- IBG N/A
- Average True Range (ATR)
- MYNZ 0.12
- IBG 0.00
- MACD
- MYNZ 0.02
- IBG 0.00
- Stochastic Oscillator
- MYNZ 9.27
- IBG 0.00
About MYNZ Mainz Biomed N.V.
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.
About IBG Innovation Beverage Group Limited Ordinary Shares
Innovation Beverage Group Ltd is a developer, manufacturer, marketer, exporter, and retailer of a growing beverage portfolio of 70 formulations across 14 alcoholic and non-alcoholic brands. The company's focus is on premium and super premium brands. The Group has two reportable geographic segments: Australia and the United States.